Poly Medicure Limited

BSE: 531768 NSE: POLYMED
Poly Medicure Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN L40300DL1995PLC066923 Incorporated 30 March 1995 ROC Delhi HQ New Delhi, Delhi, India
Active Listed - NSE: POLYMED · BSE: 531768 Public Limited Company healthcare
Data last updated
Market Cap
₹17,394 Cr
POLYMED · NSE
Share Price
₹1,724.40
+0.49% today
Revenue
₹1,875 Cr
FY 2025-26 · +18.3% YoY
EBITDA
₹439 Cr
Margin 23.4%
Net Profit
₹265 Cr
FY 2025-26 · -6.6% YoY
P/E (TTM)
54.7x
P/B 5.6x
ROE
9.0%
ROCE 12.4%
Debt / Equity
0.09
Interest cover 6.6x

About Poly Medicure Limited

Data last updated: 27 September 2026

Poly Medicure Limited is a public limited company based in New Delhi, Delhi, India. It specialises in medical and laboratory equipment, a part of the broader healthcare sector. Incorporated on 30 March 1995, the company has been in operation for over 31 years.

Registered with ROC Delhi under CIN L40300DL1995PLC066923. Listed on BSE: 531768 and NSE: POLYMED.

Capital: an authorised share capital of ₹60 Cr and a paid-up capital of ₹50.68 Cr. Formerly known as Polymedicure Limited. It is led by directors including Vishal Gupta and Alessandro Balboni.

Last AGM: 25 September 2025. Financial statements filed for year ended 31 March 2025. Office: Property No. – 232B Third Floor Okhla Industrial Estate Phase – Iii, New Delhi, Delhi, India – 110020.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹1,875.26 Cr, a growth of 12.3% compared to the previous year. The net worth stands at ₹3,106.17 Cr (up 12.31% YoY). Total assets are valued at ₹3,581.4 Cr (up 21.03% YoY).

The company has a workforce of approximately 2,683 employees as per the latest available data.

The company is associated with 1 brand - Polymedicure. As per MCA filings, the company has open charges of ₹549.5 Cr and satisfied charges of ₹140.2 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website polymedicure.com.

Company Details of Poly Medicure Limited
CIN L40300DL1995PLC066923
Registration Number 066923
Incorporation Date 30 March 1995
ROC Delhi
Listing Status Listed (BSE: 531768, NSE: POLYMED)
Company Status Active
Date of Last AGM 25 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Himanshu Baid Managing Director Rishi Baid Whole-Time Director Pankaj Kumar Gupta Whole-Time Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    polymedicure.com
  • Social Media
  • Registered Address
    Property No. – 232B Third Floor Okhla Industrial Estate Phase – Iii, New Delhi, Delhi, India – 110020
  • Industry
    Healthcare, Medical & Laboratory Equipment
Company report
Poly Medicure Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Poly Medicure Limited report

Financials, compliance, directors, charges, ownership and filings for Poly Medicure Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Poly Medicure Limited

Poly Medicure Limited has one previous CIN (Corporate Identification Number): L74899DL1995PLC066923. The current CIN is L40300DL1995PLC066923, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L40300DL1995PLC066923 Current
L74899DL1995PLC066923 Previous

Associated Brands with Poly Medicure Limited

Poly Medicure Limited operates one associated brand: Polymedicure. These brands represent Poly Medicure Limited's diversified market presence and brand portfolio.

Brand Description Website
Polymedicure
Medical devices for oncology, dialysis, and respiratory care are manufactured. polymedicure.com

Business Activity of Poly Medicure Limited

Poly Medicure Limited is engaged in the principal business activity of manufacturing, with detailed activities including plastic products, non-metallic mineral products, rubber products, fabricated metal products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C8 Plastic products, non-metallic mineral products, rubber products, fabricated metal products Locked
Premium access

Business activity turnover details for Poly Medicure Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Poly Medicure Limited

Poly Medicure Limited is audited by M C BHANDARI & CO. for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
M C BHANDARI & CO. Locked Locked Locked
Premium access

Complete auditor history for Poly Medicure Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors and KMP of Poly Medicure Limited

Poly Medicure Limited currently reports 14 directors and 1 key managerial person. 10 former directors have served the organization.

Current Directors and KMP
Name Designation Appointment Date Tenure Status
Vishal Gupta
Also directs: Woodstory Llp, Semac Construction Limited, Ashiana Housing Limited and 5 more
Director 28 Oct 2024 1 Years 10 Months Current
Alessandro Balboni Additional Director 10 May 2018 8 Years 4 Months Current
Ambrish Mithal Director 04 Aug 2022 4 Years 1 Months Current
Avinash Chandra Company Secretary 01 May 2015 11 Years 4 Months Current
Vimal Bhandari
Also directs: Kec International Limited, Escorts Kubota Limited, Jk Lakshmi Cement Limited and 1 more
Director 22 Jul 2024 2 Years 2 Months Current
Sonal Mattoo
Also directs: Syntegon Telstar India Private Limited, Pramerica Life Insurance Limited
Director 29 Aug 2020 6 Years 0 Months Current
Showing 6 of 15 current directors and KMP. View all directors and KMP

Financials of Poly Medicure Limited FY 2025-26 filings available

Poly Medicure Limited reported revenue of ₹1,875.26 Cr (up 12.3% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹1,875 Cr
+12.3% YoY
EBITDA
₹439 Cr
-3.8% YoY
Profit After Tax
₹265 Cr
-6.6% YoY
Net Worth
₹3,106 Cr
+12.3% YoY
Total Assets
₹3,581 Cr
+21.0% YoY
Total Debt
₹354 Cr
+96.2% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue1,8751,6701,3761,115923786687
Revenue growth+18.3%+19.5%+19.8%+19.7%+24.2%+9.4%+8.7%
EBITDA439456360267215216166
EBITDA margin+23.4%+27.3%+26.2%+24.0%+23.3%+27.5%+24.2%
Profit before tax427453344237195180126
Net profit26528425917214113595.77
Net profit margin+14.1%+17.0%+18.8%+15.4%+15.2%+17.2%+13.9%
EPS (₹)31.7833.4126.9118.6915.2814.1710.86
Balance sheet
Total assets3,5812,9591,6541,3991,2221,111648
Net worth3,1062,7661,4701,2421,087966435
Total debt354180174149127137207
Cash & bank87.8715114718315.4429.5625.36
Net working capital923676522525308260198
Cash flow
Cash from operations246233266191123119131
Cash from investing(224)(1,187)(241)(179)(85.33)(436)(109)
Cash from financing20.15951(20.15)(12.51)(35.34)317(20.51)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue525535494444403441424420
Revenue growth (YoY)+30.3%+21.3%+16.4%+5.7%+4.8%+16.6%+24.9%+24.5%
Other income34.9619.4727.9534.9143.4426.5823.5226.85
EBITDA125110104115106119115115
EBITDA margin+23.8%+20.7%+21.1%+25.8%+26.2%+27.1%+27.0%+27.4%
Depreciation36.2538.2328.7624.9323.2621.0321.5120.71
Interest6.506.415.962.972.952.173.333.34
Profit before tax11785.2397.61122123123113118
Tax32.0320.1826.8029.9029.8731.0228.0030.53
Net profit85.2865.0570.8191.7993.0791.8285.2287.46
EPS (₹)8.486.536.999.069.178.928.489.01
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue1,6621,6021,3071,068879747646
Revenue growth+5.8%+20.7%+19.3%+20.5%+23.9%+11.0%+6.9%
EBITDA441448351266214210162
EBITDA margin+26.6%+28.0%+26.9%+24.9%+24.3%+28.2%+25.1%
Profit before tax448443335237195173122
Net profit27927723617213312992.27
Net profit margin+16.8%+17.3%+18.1%+16.1%+15.1%+17.2%+14.3%
EPS (₹)33.1532.7026.2318.6615.2313.5110.47
Balance sheet
Total assets3,3212,9271,6311,3781,1941,087629
Net worth3,0532,7441,4581,2341,077954429
Total debt252172164137111126194
Cash & bank42.581431371718.3127.4022.39
Net working capital729640486486281241181
Cash flow
Cash from operations245230256197126116127
Cash from investing(268)(1,184)(237)(189)(88.71)(434)(106)
Cash from financing28.03953(17.32)(7.89)(39.71)319(22.25)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue431443419417384421411402
Revenue growth (YoY)+12.3%+5.2%+1.9%+3.5%+4.5%+16.6%+28.1%+25.8%
Other income28.6515.1229.5533.7241.5223.9521.7527.24
Total expenses310322313305283305295290
EBITDA121121105111101116115113
EBITDA margin+28.0%+27.3%+25.2%+26.7%+26.4%+27.6%+28.1%+28.0%
Depreciation26.4725.5125.0624.1522.8421.3320.6919.97
Interest4.383.893.942.782.812.173.133.13
Profit before tax119107106118117116113117
Tax30.5226.1827.6328.9629.1429.8428.2429.71

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 27 Sep 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue525535494444403441424420
Revenue growth (YoY)+30.3%+21.3%+16.4%+5.7%+4.8%+16.6%+24.9%+24.5%
Other income34.9619.4727.9534.9143.4426.5823.5226.85
EBITDA125110104115106119115115
EBITDA margin+23.8%+20.7%+21.1%+25.8%+26.2%+27.1%+27.0%+27.4%
Depreciation36.2538.2328.7624.9323.2621.0321.5120.71
Interest6.506.415.962.972.952.173.333.34
Profit before tax11785.2397.61122123123113118
Tax32.0320.1826.8029.9029.8731.0228.0030.53
Net profit85.2865.0570.8191.7993.0791.8285.2287.46
EPS (₹)8.486.536.999.069.178.928.489.01
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue1,8751,6701,3761,115923786687
Revenue growth+18.3%+19.5%+19.8%+19.7%+24.2%+9.4%+8.7%
Other income12694.3161.2738.1140.3521.7320.60
Total expenses1,4371,2141,016848708570521
Employee cost402302246203164142139
EBITDA439456360267215216166
EBITDA margin+23.4%+27.3%+26.2%+24.0%+23.3%+27.5%+24.2%
Depreciation11683.1863.4457.1753.9547.5240.53
Interest21.4214.3213.5610.866.1610.6420.48
Profit before tax427453344237195180126
Tax10711486.0158.2148.7444.1829.85
Net profit26528425917214113595.77
Net profit margin+14.1%+17.0%+18.8%+15.4%+15.2%+17.2%+13.9%
EPS (₹)31.7833.4126.9118.6915.2814.1710.86
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital50.6850.6647.9947.9747.9547.9444.12
Reserves & surplus3,0552,7151,4221,1941,040918391
Shareholders' funds (net worth)3,1062,7661,4701,2421,087966435
Minority interest43.070.000.000.000.000.000.00
Secured loans254175166140118129200
Unsecured loans99.815.557.758.539.008.066.97
Total debt354180174149127137207
Total liabilities3,5812,9591,6541,3991,2221,111648
Assets
Gross block2,4741,5961,3121,025822712605
Net block1,6941,084867635488426363
Capital work in progress98.7210175.7178.1643.4021.2124.71
Investments7551,07616712634635425.39
Inventories434286221209168126112
Sundry debtors531350270235207156127
Cash & bank balances87.8715114718315.4429.5625.36
Loans & advances15079.8064.2461.2756.4147.1837.30
Total current assets1,203866702688447359302
Total current liabilities27919118016313899.21104
Net working capital923676522525308260198
Total assets3,5812,9591,6541,3991,2221,111648
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash8.7012.057.067.764.954.864.32
Net cash from operating activities246233266191123119131
Net cash from investing activities(224)(1,187)(241)(179)(85.33)(436)(109)
Net cash from financing activities20.15951(20.15)(12.51)(35.34)317(20.51)
Net change in cash42.53(3.35)4.99(0.70)2.800.100.54
Closing cash87.8715114718315.4429.5625.36
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+12.3%+21.4%+23.4%+20.8%+17.4%+14.4%+12.5%
EBITDA growth-3.8%+26.6%+34.6%+24.4%-0.7%+30.3%+26.6%
PBT growth-5.5%+31.4%+45.0%+21.6%+8.4%+43.2%+25.6%
Net income growth-6.6%+9.7%+50.3%+22.3%+4.1%+41.1%+48.0%
Revenue CAGR (3Y)+18.9%+21.9%+20.5%+17.5%+14.8%+14.8%+14.7%
EBITDA CAGR (3Y)+17.9%+28.5%+18.5%+17.2%+17.9%+21.1%+21.1%
Profitability & leverage
Net income margin+17.1%+20.3%+18.8%+16.1%+15.9%+17.3%+14.0%
Return on capital employed+12.4%+20.2%+23.4%+19.0%+17.3%+21.7%+24.4%
Return on net worth+9.0%+16.0%+19.1%+15.4%+14.3%+19.4%+23.5%
Debt / equity0.090.080.120.120.130.250.45
Long-term debt / equity0.010.000.010.020.050.130.25
Interest cover6.633.844.575.173.826.3016.31
Efficiency & per share
Fixed asset turnover0.921.151.181.211.201.191.23
Inventory turnover5.216.596.405.926.266.597.02
Debtors turnover4.265.395.445.055.095.565.38
EPS (₹)31.7833.4126.9118.6915.2814.1710.86
Dividend per share (₹)3.503.503.003.002.502.502.00
Book value per share (₹)306.45272.95153.18129.41113.40100.7149.27
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue431443419417384421411402
Revenue growth (YoY)+12.3%+5.2%+1.9%+3.5%+4.5%+16.6%+28.1%+25.8%
Other income28.6515.1229.5533.7241.5223.9521.7527.24
Total expenses310322313305283305295290
EBITDA121121105111101116115113
EBITDA margin+28.0%+27.3%+25.2%+26.7%+26.4%+27.6%+28.1%+28.0%
Depreciation26.4725.5125.0624.1522.8421.3320.6919.97
Interest4.383.893.942.782.812.173.133.13
Profit before tax119107106118117116113117
Tax30.5226.1827.6328.9629.1429.8428.2429.71
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue1,6621,6021,3071,068879747646
Revenue growth+5.8%+20.7%+19.3%+20.5%+23.9%+11.0%+6.9%
Other income12089.7758.1836.2938.7319.2918.58
Total expenses1,2211,154956802665537484
Employee cost313280229188150131127
EBITDA441448351266214210162
EBITDA margin+26.6%+28.0%+26.9%+24.9%+24.3%+28.2%+25.1%
Depreciation97.9081.3961.5755.6452.5446.3139.28
Interest15.5213.5012.8510.195.369.9519.76
Profit before tax448443335237195173122
Tax11211283.1757.7848.7043.8729.40
Net profit27927723617213312992.27
Net profit margin+16.8%+17.3%+18.1%+16.1%+15.1%+17.2%+14.3%
EPS (₹)33.1532.7026.2318.6615.2313.5110.47
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital50.6850.6647.9947.9747.9547.9444.12
Reserves & surplus3,0022,6941,4101,1861,029906385
Shareholders' funds (net worth)3,0532,7441,4581,2341,077954429
Secured loans248170160135109123190
Unsecured loans3.192.603.942.581.433.294.32
Total debt252172164137111126194
Total liabilities3,3212,9271,6311,3781,1941,087629
Assets
Gross block1,7941,5361,255965768660555
Net block1,2171,047831598451390328
Capital work in progress95.8592.7970.7177.7442.9721.1824.58
Investments1,2431,12622118138438557.95
Inventories281250193183150109101
Sundry debtors442340259221191149120
Cash & bank balances42.581431371718.3127.4022.39
Loans & advances13476.6563.0056.4854.3942.9633.58
Total current assets900810652631404329277
Total current liabilities17117016614512387.7296.10
Net working capital729640486486281241181
Total assets3,3212,9271,6311,3781,1941,087629
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash0.552.140.380.632.791.892.91
Net cash from operating activities245230256197126116127
Net cash from investing activities(268)(1,184)(237)(189)(88.71)(434)(106)
Net cash from financing activities28.03953(17.32)(7.89)(39.71)319(22.25)
Net change in cash5.39(1.59)1.76(0.25)(2.16)0.90(1.02)
Closing cash42.581431371718.3127.4022.39
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+3.8%+22.5%+22.4%+21.5%+17.7%+15.7%+10.1%
EBITDA growth-1.5%+27.6%+31.8%+24.5%+1.7%+29.7%+21.1%
PBT growth+1.1%+32.2%+41.4%+21.6%+12.3%+42.4%+21.2%
Net income growth+0.9%+17.0%+37.5%+29.2%+3.3%+39.6%+40.7%
Revenue CAGR (3Y)+15.9%+22.1%+20.5%+18.2%+14.4%+13.7%+13.7%
EBITDA CAGR (3Y)+18.3%+28.0%+18.6%+18.0%+16.9%+20.1%+19.9%
Profitability & leverage
Net income margin+20.2%+20.7%+19.3%+16.8%+16.6%+17.3%+14.3%
Return on capital employed+13.4%+20.0%+23.1%+19.2%+17.5%+21.4%+24.2%
Return on net worth+9.6%+15.8%+18.7%+15.5%+14.4%+18.7%+22.8%
Debt / equity0.070.080.110.110.120.230.43
Long-term debt / equity0.000.000.010.020.050.130.25
Interest cover4.523.684.444.843.326.0716.07
Efficiency & per share
Fixed asset turnover1.001.151.181.231.231.231.27
Inventory turnover6.267.236.966.416.777.117.38
Debtors turnover4.255.345.445.185.175.555.28
EPS (₹)33.1532.7026.2318.6615.2313.5110.47
Dividend per share (₹)3.503.503.003.002.502.502.00
Book value per share (₹)301.18270.83151.95128.63112.3099.5048.65
Want more history and ratios?
You're viewing the latest exchange-filed financials for Poly Medicure Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Poly Medicure Limited

As per the shareholding pattern for the quarter ended Jun 2026, promoters hold 62.40%, foreign institutional investors hold 5.60%, domestic institutional investors hold 16.00%, retail and other public shareholders hold 16.00% of Poly Medicure Limited.

Promoters: 62.40%DII (Domestic Institutional): 16.00%FII (Foreign Institutional): 5.60%Retail & Others: 16.00%
Jun 2026
QUARTER
62.40% Promoters
16.00% DII (Domestic Institutional)
5.60% FII (Foreign Institutional)
16.00% Retail & Others
Promoter holding - history
Now 62.40% · Jun 2026High 62.40% · Sep 2025Low 62.40% · Sep 2025
61%61.8%62.5%63.3%64%Sep 2025Dec 2025Mar 2026Jun 2026Sep 2025: 62.40%Dec 2025: 62.40%Mar 2026: 62.40%Jun 2026: 62.40%62.40%62.40%
Shareholding trend - last 6 quarters
Jun 2026Mar 2026Dec 2025Sep 2025
Promoters62.40%62.40%62.40%62.40%
Public37.60%37.60%37.60%37.60%

Charges & Borrowings of Poly Medicure Limited

Open charges
₹549.5 Cr
Satisfied charges
₹140.2 Cr
Breakdown by lending institutions
Sbicap Trustee Company Limited₹402.00 Cr
Hdfc Bank Limited₹112.50 Cr
Citi Bank N.A.₹25.00 Cr
The Hongkong and Shanghai Banking Corporation Limited₹10.00 Cr
Latest charge details
DateLenderAmountStatus
27 Apr 2026 Hdfc Bank Limited ₹70 Cr Open
18 Apr 2025 Hdfc Bank Limited ₹30 Cr Open
07 Nov 2017 Hdfc Bank Limited ₹12.5 Cr Open
14 Feb 2017 The Hongkong and Shanghai Banking Corporation Limited ₹10 Cr Open
15 Jun 2011 Citi Bank N.A. ₹25 Cr Open

Total charge records: 11 View all charges

Employees and EPFO Compliance at Poly Medicure Limited

Poly Medicure Limited has a workforce of 2,683 employees as of Apr 05, 2024.

Employee count
2,683
Active EPFO establishments
9
Employee growth
15.95%
Premium access

Employee and EPFO history for Poly Medicure Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Poly Medicure Limited

Premium access

GST registrations and filing compliance for Poly Medicure Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Poly Medicure Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Poly Medicure Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Poly Medicure Limited

Premium access

MSME payment history for Poly Medicure Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Poly Medicure Limited

Premium access

Corporate group structure for Poly Medicure Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Poly Medicure Limited

Premium access

MCA filings and documents for Poly Medicure Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Poly Medicure Limited

Charges
27 Apr 2026
A charge with Hdfc Bank Limited amounted to Rs. 70.00 Cr with Charge ID 101294435 was registered on 27 Apr 2026.
Charges
12 Feb 2026
A charge with Sbicap Trustee Company Limited of Rs. 402.00 Cr registered on 08 Aug 2002 with Charge ID 90062621 was modified on 12 Feb 2026.
Activity
25 Sep 2025
Poly Medicure Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Directors
08 Aug 2025
Pankaj Kumar Gupta was appointed as a Whole-time director on 08 Aug 2025 & has been associated with this company since 1 year 1 month.
Directors
06 May 2025
Vishal Baid was appointed as a Director on 06 May 2025 & has been associated with this company since 1 year 4 months.
Charges
18 Apr 2025
A charge with Hdfc Bank Limited amounted to Rs. 30.00 Cr with Charge ID 101121003 was registered on 18 Apr 2025.

Recent News on Poly Medicure Limited

Stocks that will see action today: February 3, 2025
03 Feb 2025 · Thehindubusinessline

Frequently Asked Questions about Poly Medicure Limited

Poly Medicure Limited is an active public limited company in the healthcare sector based in New Delhi, Delhi, India. It was incorporated on 30 March 1995 (31+ years old) and is registered under CIN L40300DL1995PLC066923. Listed on BSE: 531768 and NSE: POLYMED. The company has 2,683 employees.

Poly Medicure Limited reported revenue of ₹1,875.26 Cr for FY 2025-26 (up 12.3% YoY) based on consolidated financials.

The current directors and KMP of Poly Medicure Limited are:

The primary industry of Poly Medicure Limited is healthcare. The company specifically operates in medical and laboratory equipment. The company is currently active in this sector.

Yes. Poly Medicure Limited is listed on both BSE (code: 531768) and NSE (symbol: POLYMED).

Poly Medicure Limited can be reached at the registered office: Property No. – 232B Third Floor Okhla Industrial Estate Phase – Iii, New Delhi, Delhi, India – 110020, or through the website polymedicure.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available